Srikala Addepalli, MBBS

Assistant Professor of Medicine
Email address srikala.addepalli@duke.edu

Education and Training

  • Hematology/Oncology Fellowship, The Brody School of Medicine at East Carolina University, 2014 - 2017
  • Internal Medicine Residency, University of Pennsylvania School of Medicine, 2011 - 2014
  • M.B.B.S., Gandhi Medical College and Hospital (India), 2002

Publications

Addepalli, S, Brigham, D, and Liles, DK. "Unusual disease characteristics of multiple myeloma in eastern North Carolina." May 20, 2017.

Full Text

Addepalli, S, Stroud, CRG, Cherukuri, SD, Cherry, CR, Sharma, N, and Parent, T. "Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases." 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL. June 2, 2017 - June 7, 2017.: AMER SOC CLINICAL ONCOLOGY, March 1, 2017.

Scholars@Duke

Stroud, CR, Hegde, A, Cherry, C, Naqash, AR, Sharma, N, Addepalli, S, Cherukuri, S, Parent, T, Hardin, J, and Walker, P. "Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners (January 2017): 1078155217745144-null.

PMID
29207939
Full Text

Sharma, N, Stroud, CRG, Walker, PR, Cherry, CR, Cherukuri, SD, Addepalli, S, Parent, T, and Hardin, J. "Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors." May 20, 2016.

Full Text